De Novo Mutations in the Genome Organizer CTCF Cause Intellectual Disability
Anne Gregor(University of Bern), Christiane Zweier(University Hospital of Bern)
Cited by 171
Related Papers
Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2000|719
Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection
|The Journal of Experimental Medicine|2015|258
Clinical and molecular description of 19 patients with GATAD2B-Associated Neurodevelopmental Disorder (GAND)
|European Journal of Medical Genetics|2020|13
Genotype-phenotype correlations in RHOBTB2-associated neurodevelopmental disorders
|Genetics in Medicine|2023|12